| Dr Andrew Lauronilla, MD | |
|
1125 W Spruce St, Olathe, KS 66061-3123 | |
| (913) 826-4200 | |
| Not Available |
| Full Name | Dr Andrew Lauronilla |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 34 Years |
| Location | 1125 W Spruce St, Olathe, Kansas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942242672 | NPI | - | NPPES |
| 2068914 | Other | KS | CIGNA |
| 9602 | Other | KS | PREFERRED HEALTH SYSTEMS |
| 104024 | Other | KS | BLUE CROSS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 04-27867 (Kansas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Johnson County Mental Health Center | 0547156903 | 25 |
News Archive
Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.
On the U.S. Global Leadership Coalition (USGLC) blog, Ashley Chandler, deputy policy director at the USGLC, discusses USAID's new guidance on Building Resilience to Recurrent Crisis, writing that the policy "is about using existing development dollars more effectively in disaster prone regions, so that less humanitarian assistance is needed in the future."
Ontario's doctors commend today's announcement by the provincial government which cracks down on contraband cigarettes and enhances support for people who want to quit smoking.
Could flavored electronic cigarettes (e-cigarettes) cause bodily harm? There has been a rapid rise in e-cigarette use, partially due to flavoring additives in tobacco products and perception of less harm than traditional combustible cigarettes.
› Verified 2 days ago
| Entity Name | County Of Sedgwick |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629281373 PECOS PAC ID: 2961304779 Enrollment ID: O20040122000873 |
News Archive
Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.
On the U.S. Global Leadership Coalition (USGLC) blog, Ashley Chandler, deputy policy director at the USGLC, discusses USAID's new guidance on Building Resilience to Recurrent Crisis, writing that the policy "is about using existing development dollars more effectively in disaster prone regions, so that less humanitarian assistance is needed in the future."
Ontario's doctors commend today's announcement by the provincial government which cracks down on contraband cigarettes and enhances support for people who want to quit smoking.
Could flavored electronic cigarettes (e-cigarettes) cause bodily harm? There has been a rapid rise in e-cigarette use, partially due to flavoring additives in tobacco products and perception of less harm than traditional combustible cigarettes.
› Verified 2 days ago
| Entity Name | Johnson County Mental Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174513444 PECOS PAC ID: 0547156903 Enrollment ID: O20051112000009 |
News Archive
Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.
On the U.S. Global Leadership Coalition (USGLC) blog, Ashley Chandler, deputy policy director at the USGLC, discusses USAID's new guidance on Building Resilience to Recurrent Crisis, writing that the policy "is about using existing development dollars more effectively in disaster prone regions, so that less humanitarian assistance is needed in the future."
Ontario's doctors commend today's announcement by the provincial government which cracks down on contraband cigarettes and enhances support for people who want to quit smoking.
Could flavored electronic cigarettes (e-cigarettes) cause bodily harm? There has been a rapid rise in e-cigarette use, partially due to flavoring additives in tobacco products and perception of less harm than traditional combustible cigarettes.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Andrew Lauronilla, MD 6000 Lamar Ave Ste 130, Mission, KS 66202-3234 Ph: (913) 826-4200 | Dr Andrew Lauronilla, MD 1125 W Spruce St, Olathe, KS 66061-3123 Ph: (913) 826-4200 |
News Archive
Based on promising data from initial clinical trials in late 2014, WHO with the Health Ministry of Guinea, Médecins Sans Frontières, Epicentre and The Norwegian Institute of Public Health, will launch a Phase III trial in Guinea on 7 March to test the VSV-EBOV vaccine for efficacy and effectiveness to prevent Ebola.
The Juvenile Diabetes Research Foundation announced today that it is partnering with Living Cell Technologies, a New Zealand-based biotechnology company focused on developing cell based therapeutics, in a Phase II clinical trial to study the safety and effectiveness of transplanting encapsulated insulin-producing cells from pigs as a treatment for type 1 diabetes with significant hypoglycemia unawareness.
On the U.S. Global Leadership Coalition (USGLC) blog, Ashley Chandler, deputy policy director at the USGLC, discusses USAID's new guidance on Building Resilience to Recurrent Crisis, writing that the policy "is about using existing development dollars more effectively in disaster prone regions, so that less humanitarian assistance is needed in the future."
Ontario's doctors commend today's announcement by the provincial government which cracks down on contraband cigarettes and enhances support for people who want to quit smoking.
Could flavored electronic cigarettes (e-cigarettes) cause bodily harm? There has been a rapid rise in e-cigarette use, partially due to flavoring additives in tobacco products and perception of less harm than traditional combustible cigarettes.
› Verified 2 days ago
Dr. Linda J Kohler, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1925 E Willow Dr, Olathe, KS 66062 Phone: 913-393-9889 Fax: 913-393-9998 | |
Mr. Todd J Mekles, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13351 S Arapaho Dr, Olathe, KS 66062 Phone: 913-353-3000 Fax: 913-353-3001 | |
Jordan Calabrese, Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 913-791-4200 | |
Khan Noohani, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1125 W Spruce St, Olathe, KS 66061 Phone: 913-826-4200 Fax: 913-826-1589 | |
Aman S Gill, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 601 N Mur Len Rd, # 8, Olathe, KS 66062 Phone: 913-764-5100 Fax: 913-764-5101 | |
David Matthew Willey, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 13351 S Arapaho Dr, Olathe, KS 66062 Phone: 913-353-3000 Fax: 913-353-3001 | |
Dr. Faisal Aftab Ansari, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 20333 W 151st St, Olathe, KS 66061 Phone: 347-462-7668 |